Compare Proprius Pharmaceuticals vs Shire Pharmaceuticals Group
Customers evaluate the quality of Proprius Pharmaceuticals's products using the following success metrics.
Overview
Proprius Pharmaceuticals is based in United States
Cypress Bioscience, Inc. (NASDAQ: CYPB) and Proprius Pharmaceuticals, Inc., a privately held, San Diego-based specialty pharmaceutical company, today announced that Cypress will acquire Proprius in a transaction that includes an upfront payment of $37.5 million in cash as well as an additional $37.5 million in potential milestone-related payments associated with the development of Proprius' therapeutic candidates.
Shire Pharmaceuticals Group is based in United States
Shire Pharmaceuticals Group is an international specialty pharmaceutical company with a strategic focus on four therapeutic areas: central nervous system disorders, metabolic diseases, oncology and gastroenterology.
Demo Video
Leadership
Michael J Walsh (Chief Executive Officer, President)
Gregory D. Flexter (Executive Vice President)
Investors
Cypress Bioscience, Forward Ventures
Supernus Pharmaceuticals, Richwood Pharmaceutical
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Proprius Pharmaceuticals has not claimed their profile.
Work for Proprius Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Proprius Pharmaceuticals?
Claim your profile now.
Information not available because Shire Pharmaceuticals Group has not claimed their profile.
Work for Shire Pharmaceuticals Group? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Shire Pharmaceuticals Group?
Claim your profile now.